Frontiers in Psychiatry | Psychopharmacology

Case Report

Published on 28 Nov 2023

Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy

in Psychopharmacology

Alexander Kaltenboeck
Elisa Foerster
Sabrina Strafner
Ulrike Demal
Nilufar Mossaheb
Fabian Friedrich

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1291077

3,992 views
1 citation

Mini Review

Published on 28 Nov 2023

Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies

in Psychopharmacology

György Purebl
Katharina Schnitzspahn
Éva Zsák

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1268194

6,450 views
8 citations

Original Research

Published on 27 Nov 2023

Anti-depressant medication use is a risk factor for incident knee surgery and opioid use in patients with knee osteoarthritis

in Psychopharmacology

Yongqiang Zheng
Jinshan Zhang
Zefeng Wang
Xiaofeng Liu
Yongquan Xu
Yangzhen Fang
Zhenyu Lin
Liang Lin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1243124

1,245 views

Case Report

Published on 23 Nov 2023

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

in Psychopharmacology

Anya Ragnhildstveit
Ryan Khan
Paul Seli
Lisa Claire Bass
River Jude August
Miriam Kaiyo
Nathaniel Barr
Laura Kate Jackson
Michael Santo Gaffrey
Joseph Peter Barsuglia

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1271152

19,436 views
5 citations

Review

Published on 23 Nov 2023

Overcoming the myths of esketamine administration: different and not difficult

in Psychopharmacology

Florian Buchmayer
Siegfried Kasper

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1279657

7,209 views
5 citations

Perspective

Published on 21 Nov 2023

Biological studies of clavine alkaloids targeting CNS receptors

in Psychopharmacology

Nikhil R. Tasker
Ethan J. Pazur
Peter Wipf

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1286941

2,599 views
3 citations

Editorial

Published on 17 Nov 2023

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms

in Psychopharmacology

Roberto Esposito
HuaLin Cai
Wenbin Guo
Haibin Dai
Pei Jiang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1269307

1,364 views

Original Research

Published on 13 Nov 2023

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample

in Psychopharmacology

Tor-Morten Kvam
Malin V. Uthaug
Kristoffer A. A. Andersen
Birk Berggrav Refsum
Paula Aarseth Tunstad
Lowan Han Stewart
Henrik Børsting Jacobsen
Cato Grønnerød

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1287196

3,814 views
7 citations

Editorial

Published on 06 Nov 2023

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression

in Psychopharmacology

Georgios Mikellides
Theodoros Koutsomitros
Olympia Evagorou
Nikolaos Gkouvas
Kuan-Pin Su
Panayiota Michael

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1306117

2,720 views

Original Research

Published on 03 Nov 2023

The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization

in Psychopharmacology

Eric T. Monson
Sachi Shastri
Danli Chen
Stacy L. Madden
Brooks R. Keeshin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1271165

1,903 views

Original Research

Published on 02 Nov 2023

Home-administered transcranial direct current stimulation with asynchronous remote supervision in the treatment of depression: feasibility, tolerability, and clinical effectiveness

in Psychopharmacology

Theodoros Koutsomitros
Sandra A. Schwarz
Kenneth T. van der Zee
Teresa Schuhmann
Alexander T. Sack

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1206805

4,267 views
2 citations

Case Report

Published on 25 Oct 2023

Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study

in Psychopharmacology

Steffen Reissmann
Matthias Hartmann
Andreas Kist
Matthias E. Liechti
Kurt Stocker

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1197697

2,971 views

Editorial

Published on 19 Oct 2023

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges

in Psychopharmacology

Brian S. Barnett
Anahita Bassir Nia
Nathan B. Sackett
Jeremy Weleff

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1305478

2,770 views

Case Report

Published on 10 Oct 2023

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report

in Psychopharmacology

Jianhong Wu
Jiao Yu
Kankan Qu
Jiajun Yin
Chunming Zhu
Xiaowei Liu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1257984

3,992 views
3 citations

Original Research

Published on 06 Oct 2023

Paliperidone long-acting injection in the treatment of an adolescent with schizophrenia with fluctuating mental symptoms during menstrual period: a case report

in Psychopharmacology

Feng Wang
Juan Chen
Linglin Guo
Zhixiong Li
Zhe Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1276983

2,989 views
1 citation

Original Research

Published on 03 Oct 2023

Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting

in Psychopharmacology

Philipp Bohny
Soenke Boettger
Josef Jenewein

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1257755

2,856 views
3 citations